New prospects in the prevention of otitis media

Annals of Medicine

Volumn 28, Issue 1, 1996, Pages 23-30

  Heikkinen, Terho ^a   Ruuskanen, Olli ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bacterial vaccines; Otitis media; Prevention and control; Respiratory tract infections; Viral vaccines

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE;

ADENOIDECTOMY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; OTITIS MEDIA; PRIORITY JOURNAL; REVIEW; TYMPANOSTOMY TUBE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION;

EID: 0030043276     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999070     Document Type: Review

References (87)

1. Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J 1989; 8: S11-4.
2. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 1994; 124: 355-67.
3. Teele DW, Klein JO, Chase C, Menyuk P, Rosner BA, and the Greater Boston Otitis Media Study Group. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. J Infect Dis 1990; 162: 685-94.
4. Teele DW, Klein JO, Rosner B, and the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis 1989; 160: 83-94.
5. Owen MJ, Baldwin CD, Swank PR, Pannu AK, Johnson DL, Howie VM. Relation of infant feeding practices, cigarette smoke exposure, and group child care to the onset and duration of otitis media with effusion in the first two years of life. J Pediatr 1993; 123: 702-11.
6. Niemelä M, Uhari M, Möttönen M. A pacifier increases the risk of recurrent otitis media in children in day care centers. Pediatrics (in press).
7. Alho OP, Koivu M, Sorri M, Rantakalllo P. Risk factors for recurrent acute otitis media and respiratory infection in infancy. Int J Pediatr Otorhinolaryngol 1990; 19: 151-61.
8. Ståhlberg M-R. The influence of form of day care on occurrence of acute respiratory tract infections among young children. Acta Paediatr Scand 1980; 282 (Suppl): 1-87.
9. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatr 1988; 112: 540-6.
10. Fleming DW, Cochi SL, Hightower AW, Broome CV. Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics 1987; 79: 55-60.
11. Aniansson G, Aim B, Andersson B, et al. A prospective cohort study on breast-feeding and otitis media in Swedish infants. Pediatr Infect Dis J 1994; 13: 183-8.
12. Ruuskanen O, Arola M, Putto-Laurila A, et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 1989; 8: 94-9.
13. Denny FW, Collier AM, Henderson FW. Acute respiratory infections in day care. Rev Infect Dis 1986; 8: 527-32.
14. Alho OP, Koivu M, Sorri M, Rantakallio P. The occurrence of acute otitis media in infants: a life-table analysis. Int J Pediatr Otorhinolaryngol 1991; 21: 7-14.
15. Stanley PJ, Wilson R, Greenstone MA, MacWilliam L, Cole PJ. Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 1986; 41: 519-23.
16. Agius AM, Wake M, Pahor AL, Smallman LA. Smoking and middle ear ciliary beat frequency in otitis media with effusion. Acta Otolaryngol 1995; 115: 44-9.
17. Gulya AJ. Environmental tobacco smoke and otitis media. Otolaryngol Head Neck Surg 1994; 111: 6-8.
18. Etzel RA, Pattishall EN, Haley NJ, Fletcher RH, Henderson FW. Passive smoking and middle ear effusion among children in day care. Pediatrics 1992; 90: 228-32.
19. Stenstrom R, Bernard PAM, Ben-Simhon H. Exposure to environmental tobacco smoke as a risk factor for recurrent acute otitis media in children under the age of five years. Int J Pediatr Otorhinolaryngol 1993; 27: 127-36.
20. Bauchner H, Leventhal JM, Shapiro ED. Studies of breast-feeding and infections: how good is the evidence? JAMA 1986; 256: 887-92.
21. Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM. Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics 1993; 91: 867-72.
22. Goldman AS. The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J 1993; 12: 664-72.
23. Perrin JM, Charney E, MacWhinney JB Jr, McInerny TK, Miller RL, Nazarian LF. Sulfisoxazole as chemoprophylaxis for recurrent otitis media: a double-blind crossover study in pediatric practice. N Engl J Med 1974; 291: 664-7.
24. Schwartz RH, Puglise J, Rodriguez WJ. Sulphamethoxazole prophylaxis in the otitis-prone child. Arch Dis Child 1982; 57: 590-3.
25. Liston TE, Foshee WS, Pierson WD. Sulfisoxazole chemoprophylaxis for frequent otitis media. Pediatrics 1983; 71: 524-30.
26. Varsano I, Volovitz B, Mimouni F. Sulfisoxazole prophylaxis of middle ear effusion and recurrent acute otitis media. Am J Dis Child 1985; 139: 632-5.
27. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J 1992; 11: 278-86.
28. Paradise JL. Antimicrobial prophylaxis for recurrent acute otitis media. Ann Otol Rhinol Laryngol 1992; 101 (Suppl 155): 33-6.
29. Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion: a meta-analytic attempt to resolve the brouhaha. JAMA 1993; 270: 1344-51.
30. Prellner K, Fogle-Hansson M, Jörgensen F, Kalm O, Kamme C. Prevention of recurrent acute otitis media in otitis-prone children by intermittent prophylaxis with penicillin. Acta Otolaryngol 1994; 114: 182-7.
31. Berman S, Nuss R, Roark R, Huber-Navin C, Grose K, Herrera M. Effectiveness of continuous vs. intermittent amoxicillin to prevent episodes of otitis media. Pediatr Infect Dis J 1992; 11: 63-7.
32. Heikkinen T, Ruuskanen O, Ziegler T, Waris M, Puhakka H. Short-term use of amoxicillin clavulanate during upper respiratory tract infection for prevention of acute otitis media. J Pediatr 1995; 126: 313-6.
33. Gwaltney JM Jr. The common cold. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases, 3rd edn. New York: Churchill Livingstone, 1990: 489-93.
34. 2-interferon against rhinovirus infections in the family setting. N Engl J Med 1986; 314: 65-70.
35. 2-interferon. N Engl J Med 1986; 314: 71-5.
36. Dolin R, Relchman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580-4.
37. Clover RD, Crawford SA, Abell TD, Ramsey CN Jr, Glezen WP, Couch RB. Effectiveness of rimantadine prophylaxis of children within families. Am J Dis Child 1986; 140: 706-9.
38. Crawford SA, Clover RD, Abell TD, Ramsey CN Jr, Glezen WP, Couch RB. Rimantadine prophylaxis in children: a follow-up study. Pediatr Infect Dis J 1988; 7: 379-83.
39. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321: 1696-702.
40. Hall CB, Dolin R, Gala CL, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics 1987; 80: 275-82.
41. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993; 23: 50-79.
42. Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr 1990; 117: 792-8.
43. Grundfast KM. A review of the efficacy of systemically administered decongestants in the prevention and treatment of otitis media. Otolaryngol Head Neck Surg 1981; 89: 432-9.
44. Farr BM, Gwaltney JM Jr, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162: 1173-7.
45. Paradise JL, Bluestone CD, Rogers KD, Taylor FH. Efficacy of adenoidectomy in recurrent otitis media: historical overview and preliminary results from a randomized, controlled trial. Ann Otol Rhinol Laryngol 1980; 89 (Suppl 68): 319-21.
46. Sade J, Luntz M. Adenoidectomy in otitis media: a review. Ann Otol Rhinol Laryngol 1991; 100: 226-31.
47. Gates GA, Avery CA, Prihoda TJ, Cooper JC Jr. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med 1987; 317: 1444-51.
48. Paradise JL, Bluestone CD, Rogers KD, et al. Efficacy of adenoidectomy for recurrent otitis media in children previously treated with tympanostomy-tube placement. JAMA 1990; 263: 2066-73.
49. Bluestone CD. Management of otitis media in infants and children: current role of old and new antimicrobial agents. Pediatr Infect Dis J 1988; 7: S129-36.
50. Bluestone CD. Otitis media in children: to treat or not to treat? N Engl J Med 1982; 306: 1399-404.
51. Gebhart DE. Tympanostomy tubes in the otitis media prone child. Laryngoscope 1981; 91: 849-66.
52. Gonzalez C, Arnold JE, Woody EA, et al. Prevention of recurrent acute otitis media: chemoprophylaxis vs. tympanostomy tubes. Laryngoscope 1986; 96: 1330-4.
53. Bluestone CD, Gates GA, Paradise JL, Stool SE. Panel discussion: controversy over tubes and adenoidectomy. Pediatr Infect Dis J 1988; 7: S146-9.
54. Nelson JD, Scheetz MD, eds. Proceedings of a workshop on vaccines for otitis media. Pediatr Infect Dis J 1989; 8: S1-97.
55. Giebink GS. Preventing otitis media. Ann Otol Rhinol Laryngol 1994; 103: 20-3.
56. Mäkelä PH, Sibakov M, Herva E, et al. Pneumococcal vaccine and otitis media. Lancet 1980; 2: 547-51.
57. Sloyer JL Jr, Ploussard JH, Howie VM. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama. Rev Infect Dis 1981; 3: S119-23.
58. Teele DW, Klein JO, Bratton L, et al. Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. Rev Infect Dis 1981; 3: S113-8.
59. Karma P, Pukander J, Sipilä M, et al. Prevention of otitis media in children by pneumococcal vaccination. Am J Otolaryngol 1985; 6: 173-84.
60. Siber GR. Pneumococcal disease: prospects for a new generation of vaccines. Science 1994; 265: 1385-7.
61. Keyserling HL, Anderson EL, Martin JT. Immunogenicity of a tetravalent (types 6B; 14: 19F, 23F) pneumococcal conjugate vaccine in infants. Pediatr Res 1993; 33: 172 A.
62. Eskola J. Pneumococcal conjugate vaccines. Report Pediatr Infect Dis 1995; 5: 3-4.
63. Mäkelä PH, Leinenen M, Pukander J, Karma P. A study of the pneumococcal vaccine in prevention of clinically acute attacks of recurrent otitis media. Rev Infect Dis 1981; 3: S124-30.
64. Murphy TF, Campagnari AA, Nelson MB, Apicella MA. Somatic antigens of Haemophilus influenzae as vaccine components. Pediatr Infect Dis J 1989; 8: 866-8.
65. Karasic RB, Beste DJ, To SC-M, et al. Evaluation of pilus vaccines for prevention of experimental otitis media caused by nontypable Haemophilus influenzae. Pediatr Infect Dis J 1989; 8: S62-5.
66. Murphy TF, Nelson MB, Apicella MA. The P6 outer membrane protein of nontypeable Haemophilus influenzae as a vaccine antigen. J Infect Dis 1992; 165 (Suppl 1): 203-5.
67. Yamanaka N, Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J Pediatr 1993; 122: 212-8.
68. Helminen ME, Maciver I, Latimer JL, Cope LD, McCracken GH Jr, Hansen EJ. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun 1993; 61: 2003-10.
69. Murphy TF. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr Infect Dis J 1989; 8: 875-7.
70. Gwaltney JM Jr. Viral vaccines in the control of otitis media. Pediatr Infect Dis J 1989; 8: S78-9.
71. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991; 145: 445-8.
72. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6-30 month-old day care children. Arch Pediatr Adolesc Med 1995; 179: 1113-7.
73. Swierkosz EM, Newman FK, Anderson EL, Nugent SL, Mills GB, Belshe RB. Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children. J Infect Dis 1994; 169: 1121-4.
74. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1969; 89: 405-21.
75. Kim HW, Arrobio JO, Pyles G, et al. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 1971; 48: 745-55.
76. Belshe RB, Van Voris LP, Mufson MA. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis 1982; 145: 311-9.
77. Oien NL, Brideau RJ, Walsh EE, Wathen MW. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 1994; 12: 731-5.
78. Crowe JE Jr, Bui PT, Davis AR, Chanock RM, Murphy BR. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine 1994; 12: 783-90.
79. Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 1969; 89: 435-48.
80. Belshe RB, Newman FK. Prospects for vaccines for parainfluenza virus. Semin Pediatr Infect Dis 1991; 2: 197-201.
81. Top FH Jr, Buescher EL, Bancroft WH, Russell PK. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis 1971; 124: 155-60.
82. Steinhoff MC. Viral vaccines for the prevention of childhood pneumonia in developing nations: priorities and prospects. Rev Infect Dis 1991; 13 (Suppl 6): 562-70.
83. Kalm O, Prellner K, Christensen P. The effect of intravenous immunoglobulin treatment in recurrent acute otitis media. Int J Pediatr Otorhinolaryngol 1986; 11: 237-46.
84. Jörgensen F, Andersson B, Hanson LÅ, Nylen O, Eden CS. Gamma-globulin treatment of recurrent acute otitis media in children. Pediatr Infect Dis J 1990; 9: 389-94.
85. Shurin PA, Rehmus JM, Johnson CE, et al. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr 1993; 123: 801-10.
86. Siber GR, Leombruno D, Leszczynskl J, et al. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis 1994; 169: 1368-73.
87. Groothuis JR, Simoes EAF, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524-30.